Name: 諾瓦克斯疫苗對英國變種疫苗似乎有89%的有效性。 (Novavax vaccine appears to be 89% effective against UK variant)
Uploaded: 2021-01-30T19:41:37.000Z
Duration: 1 min 29 s

進階被動語態

the new coronavirus vaccine created by IT Novavax has been shown to be 89% effective in a trial in the UK that puts it close to those from Pfizer, Bio in Tech and Madonna.

由 IT Novavax 創建的新冠狀病毒疫苗已被證明是 89%的有效在英國的試驗，使它接近那些從輝瑞、 Bio in Tech 和麥當勞。

Novavax said on Thursday that a preliminary analysis showed the vaccine is also the first to be nearly as effective against the variant of the virus discovered in Britain.

Novavax週四表示，初步分析顯示，該疫苗也是第一個對英國發現的病毒變種幾乎同樣有效的疫苗。

However, it is less effective against the South African variant, only 60% effective among those without HIV.

然而，它對南非的變異體效果較差，在沒有艾滋病毒的人中只有60%的效果。

In a conference call, the company said they expected to take a least 2 to 3 months before they can apply for authorization from the U.

該公司在電話會議上表示，他們預計至少需要2到3個月的時間才能向美國申請授權。

It's expected they will also apply for use in the European Union.

預計他們也將申請在歐盟使用。

Approval of the Novavax vaccine would be welcome there as Europe struggles with a sparse supply of vaccines after Pfizer Bio in Tech and AstraZeneca delivered fewer doses than they hoped.

諾瓦克斯疫苗的準許將在那裡受到歡迎，因為歐洲在輝瑞生物在科技公司和阿斯利康公司交付的劑量少於他們的希望之後，正在與稀少的疫苗供應作鬥爭。

Nova VAX is already stockpiling vaccines at six manufacturing locations and says it expects eight plants and seven countries to produce two billion doses a year, including from the Serum Institute of India on the call.

Nova VAX已經在6個生產基地儲備疫苗，並表示預計8個工廠和7個國家每年將生產20億劑疫苗，包括來自印度血清研究所的電話。

Novavax executives said they were speaking with the American FDA to see if the early data was enough to apply for US emergency use authorization.

Novavax高管表示，他們正在與美國FDA溝通，看看早期數據是否足以申請美國緊急使用授權。

S and Mexico that began in December is also underway.

12月開始的S和墨西哥也在進行。

 S government to fund that trial and for 100 million doses. 

S政府資助該試驗，併為1億劑。